{"blog": [], "keywords": [{"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "rank": "1", "is_major": "N"}, {"value": "Senate", "name": "organizations", "rank": "2", "is_major": "N"}, {"value": "Elderly", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Prices (Fares, Fees and Rates)", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Turing Pharmaceuticals AG", "name": "organizations", "rank": "6", "is_major": "N"}, {"value": "Pearson, John Michael (1959- )", "name": "persons", "rank": "7", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/03/29/business/29USValeantCongressionalProbe.html", "document_type": "article", "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "type_of_material": "List", "multimedia": [], "section_name": "Business Day", "word_count": "254", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "J. Michael Pearson is expected to testify April 27 when the Senate Aging Committee holds a third hearing on soaring prices for prescription medicines.", "pub_date": "2016-03-29T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Valeant share plunge after CEO subpoenaed by Congress", "main": "Valeant Shares Plunge After C.E.O. Is Subpoenaed by Congress"}, "print_page": null, "snippet": "J. Michael Pearson is expected to testify April 27 when the Senate Aging Committee holds a third hearing on soaring prices for prescription medicines.", "_id": "56f992c038f0d874a87cb039", "slideshow_credits": null, "abstract": null}